Titelia

Holdings of T. Rowe Price Mid-Cap Growth Portfolio

T. ROWE PRICE EQUITY SERIES, INC. · 113 declared positions · as of Mar 31, 2026

Original filing · Net assets 429.6M $ · Ten largest lines: 20.6 % of the equity sleeve

Sector breakdown

  • Consumer discretionary 14.1 %
  • Technology 13.2 %
  • Health care 10.8 %
  • Industrials 10.4 %
  • Financials 4.3 %
  • Energy 3.9 %
  • Materials 2.7 %
  • Consumer staples 0.8 %
  • Communication 0.3 %
  • Unattributed 39.4 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • US 92.9 %
  • BM 2.0 %
  • GB 1.8 %
  • CA 0.8 %
  • JE 0.7 %
  • CH 0.7 %
  • NL 0.6 %
  • DE 0.4 %
  • KY 0.1 %

Shares computed on the equity sleeve.

CountryLinesValueShare
US104382.1M $92.90 %
BM18.3M $2.03 %
GB17.3M $1.76 %
CA13.1M $0.76 %
JE13M $0.73 %
CH22.8M $0.69 %
NL12.5M $0.61 %
DE11.7M $0.41 %
KY1416.7K $0.10 %

Positions

CompanySharesValueWeight
CRISPR Therapeutics AG 20,016952.2K $0.22 %
CG oncology Inc 13,968945.4K $0.22 %
DraftKings Inc 41,248891.8K $0.21 %
Caris Life Sciences Inc 48,694870.6K $0.20 %
Unity Software Inc 39,500866.6K $0.20 %
McGraw Hill Inc 59,046808.9K $0.19 %
Kymera Therapeutics Inc 9,691807.2K $0.19 %
Aurora Innovation Inc 182,317751.1K $0.17 %
Amphenol Corp 5,431686.2K $0.16 %
Revolution Medicines Inc 6,619643.7K $0.15 %
QuidelOrtho Corp 35,479582.9K $0.14 %
Nuvalent Inc 4,093419.3K $0.10 %
Bullish 11,663416.7K $0.10 %